Abstract
Three new platinum(II) complexes of lidocaine and phenylcyanamide derivative ligands of formula K[Pt(3,5-(NO2)2pcyd)2(LC)], 1, K[Pt(3,5-(CF3)2pcyd)2(LC)], 2, K[Pt(3,5-Cl2pcyd)2(LC)], 3 (LC: lidocaine, 3,5-(NO2)2pcyd: 3,5-dinitro phenylcyanamide, 3,5-(CF3)2pcyd: 3,5-bis(trifluoromethyl) phenylcyanamide, 3,5-Cl2pcyd: 3,5-dichloro phenylcyanamide) have been synthesized and fully characterized. Cellular uptake, DNA platination and cytotoxicity against a panel of human tumor cell lines were evaluated. The complexes 1–3 revealed a significant in vitro antiproliferative activity against human ovarian carcinoma (A2780), colorectal adenocarcinoma (HT29), breast (MCF-7), liver hepatocellular carcinoma (HepG-2) and lung adenocarcinoma (A549) cancer cell lines. All the complexes are more active than cisplatin and follow the trend 1 > 2 > 3. Mechanistic studies showed that the trend in cytotoxicity of the Pt(II) complexes is mainly consistent with their ability to accumulate into cancer cells and to increase intracellular basal reactive oxygen species levels, which consequently results in the loss of mitochondrial membrane potential and apoptosis induction. The complex 1 caused to approximately 80-fold higher DNA platination level with respect to cisplatin. The complexes 1–3 can considerably stimulate the production of hydrogen peroxide in a time-dependent manner. Also, the complexes 1–3 induced an increase in reactive oxygen species (ROS) production that was superior to that induced by antimycin. The complex 1 had the most effect on ROS production in comparison with other complexes.
Graphical abstract
Similar content being viewed by others
References
Ahmad S (2010) Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes. Chem Biodivers 7:543–566. doi:10.1002/cbdv.200800340
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601
Alster T, Garden J, Fitzpatrick R, Rendon M, Sarkany M, Adelglass J (2014) Lidocaine/tetracaine peel in topical anesthesia prior to laser-assisted hair removal: phase-II and phase-III study results. J Dermatol Treat 25:174–177. doi:10.3109/09546634.2012.715240
Argoff CE (2013) Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc 88:195–205. doi:10.1016/j.mayocp.2012.11.015
Berger C, Rossaint J, Van Aken H, Westphal M, Hahnenkamp K, Zarbock A (2014) Lidocaine reduces neutrophil recruitment by abolishing chemokine-induced arrest and transendothelial migration in septic patients. J Immunol 192:367–376. doi:10.4049/jimmunol.1301363
Cabral SA, Carraretto AR, Brocco MC, Baptista JFA, Gomez RS (2014) Effect of clonidine added to lidocaine for sub-tenon’s (episcleral) anesthesia in cataract surgery. J Anesth 28:70–75
Chiniforoshan H, Pourrahim N, Tabrizi L, Tavakol H, Sabzalian MR, Notash B (2014) Syntheses, studies and crystal structure of new coordination polymers of mercury(II) with phenylcyanamide derivative ligands. Inorg Chim Acta 416:85–92. doi:10.1016/j.ica.2014.03.016
Crutchley RJ (2001) Phenylcyanamide ligands and their metal complexes. Coord Chem Rev 219–221:125–155. doi:10.1016/S0010-8545(01)00324-1
De Leon-Casasola OA (2007) Multimodal approaches to the management of neuropathic pain: the role of topical analgesia. J Pain Symptom Manag 33:356–364
Dusmez D, Cengiz B, Yumrutas O, Demir T, Oztuzcu S, Demiryurek S, Tutar E, Bayraktar R, Bulut A, Simsek H, Dagli SN, Kilic T, Bagci C (2014) Effect of verapamil and lidocaine on TRPM and NaV1.9 gene expressions in renal ischemia-reperfusion. Transplant Proc 46:33–39. doi:10.1016/j.transproceed.2013.10.036
Farag E, Ghobrial M, Sessler DI, Dalton JE, Liu J, Lee JH, Zaky S, Benzel E, Bingaman W, Kurz A (2013) Effect of perioperative intravenous lidocaine administration on pain, opioid consumption, and quality of life after complex spine surgery. Anesthesiology 119:932–940. doi:10.1097/ALN.0b013e318297d4a5
Finnerup NB, Biering-Sorensen F, Johannesen IL, Terkelsen AJ, Juhl GI, Kristensen AD, Sindrup SH, Bach FW, Hensen TS (2005) Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology 102:1023–1030
Gay M, Montana AM, Batalla C, Mesas JM, Alegre M-T (2015) Design, synthesis and SAR studies of novel 1,2-bis(aminomethyl)cyclohexane platinum(II) complexes with cytotoxic activity. Studies of interaction with DNA of iodinated seven-membered 1,4-diaminoplatinocycles. J Inorg Biochem 142:15–27. doi:10.1016/j.jinorgbio.2014.09.012
Giordano D, Panini A, Pernice C, Raso MG, Barbieri V (2014) Neurologic toxicity of lidocaine during awake intubation in a patient with tongue base abscess, case report. Am J Otolaryngol 35:62–65. doi:10.1016/j.amjoto.2013.08.009
Grabner S, Modec B, Bukovec N, Bukovec P, Cemazar M, Kranjc S, Sersa G, Scancar J (2016) Cytotoxic trans-platinum(II) complex with 3-hydroxymethylpyridine: synthesis, X-ray structure and biological activity. J Inorg Biochem 161:40–51
Graham LA, Suryadi J, West TK, Kucera GL, Bierbach U (2012) Synthesis, aqueous reactivity, and biological evaluation of carboxylic acid ester-functionalized platinum-acridine hybrid anticancer agents. J Med Chem 55:7817–7827. doi:10.1021/jm300879k
Guha P, Dey A, Sen R, Chatterjee M, Chattopadhyay S, Bandyopadhyay SK (2011) Intracellular GSH depletion triggered mitochondrial bax translocation to accomplish resveratrol-induced apoptosis in the U937 cell line. J Pharmacol Exp Ther 336:206–214. doi:10.1124/jpet.110.171983
Guney M, Oral B, Bayhan G, Mungan T (2007) Intrauterine lidocaine infusion for pain relief during saline solution infusion sonohysterography: a randomized, controlled trial. J Minim Invasive Gynecol 14:304–310
Hirata M, Sakaguchi M, Mochida C, Sotozono C, Kageyama K, Kuroda Y, Hirose M (2004) Lidocaine inhibits tyrosine kinase activity of the epidermal growth factor receptor and suppresses proliferation of corneal epithelial cells. Anesthesiology 100:1206–1210
Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, Lin L (2013) The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2). J Biol Chem 288(16):10973–10985. doi:10.1074/jbc.M112.434340
Jazestani M, Chiniforoshan H, Tabrizi L, McArdle P, Notash B (2016) Synthesis, crystal structure of nickel(II) complexes of 4-nitro phenylcyanamide: comparative in vitro evaluations of biological perspectives. Inorg Chim Acta 450:402–410. doi:10.1016/j.ica.2016.06.035
Kaluerovic GN, Mijatovic SA, Zmejkovski BB, Bulatovic MZ, Gomez-Ruiz S, Mojic MK, Steinborn D, Miljkovic DM, Schmidt H, Stosic-Grujicic SD, Sabo TJ, Maksimovic-Ivanic DD (2002) Platinum(II/IV) complexes containing ethylenediamine-N, N′-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells. Metallomics 4:979. doi:10.1039/c2mt20058a
Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573–584
Khot S, Morgan CL, Kadambande S, Poole CD (2014) Use of 5% lidocaine medicated plasters for the treatment of pain in routine hospital practice: patient reported pain, functioning and satisfaction. Curr Med Res Opin 30:1573–1578. doi:10.1185/03007995.2014.915212
Krause-Heuer AM, Grìnert R, Kìhne S, Buczkowska M, Wheate NJ, Le Pevelen DD, Boag LR, Fisher DM, Kasparkova J, Malina J, Bednarski PJ, Brabec V, Aldrich-Wright JR (2009) Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells. J Med Chem 52:5474–5484. doi:10.1021/jm9007104
Letcher RJ, Zhang W, Bensimon C, Crutchley RJ (1993) (1,3-Bis(2′-pyridylimino)isoindolinato)nickel(II) complexes of phenylcyanamido ligands: crystal structure, electronic absorption spectroscopy and solvent adduct studies. Inorg Chim Acta 210:183–191. doi:10.1016/S0020-1693(00)83326-5
Liu JB, Zhang HH, Qi ZC, Zheng XY (2014) Lidocaine protects against renal and hepatic dysfunction in septic rats via downregulation of toll-like receptor 4. Mol Med Rep 9:118–124. doi:10.3892/mmr.2013.1799
Lv Z-M, Chen L, Tang J (2011) Nebulized lidocaine inhalation in the treatment of patients with acute asthma. World J Emerg Med 2:30–32
Mansouri-Torshizi H, Moghaddam MI, Divsalar A, Saboury AA (2009) Diimine platinum(II) and palladium(II) complexes of dithiocarbamate derivative as potential antitumor agents: synthesis, characterization, cytotoxicity, and detail DNA-binding studies. J Biomol Struct Dyn 26:575–586. doi:10.1080/07391102.2009.10507273
Marret E, Rolin M, Beaussier M, Bonnet F (2008) Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg 95:1331–1338. doi:10.1002/bjs.6375
Miodragovic DU, Quentzel JA, Kurutz JW, Stern CL, Ahn RW, Kandela I, Mazar A, O’Halloran TV (2013) Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes. Angew Chem Int Edit Engl 52:10749–10752. doi:10.1002/anie.201303251
Muscella A, Calabriso N, Vetrugno C, Fanizzi FP, De Pascali SA, Storelli C, Marsigliante S (2011) The platinum(II) complex [Pt(O, O′-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. Biochem Pharmacol 81:91–103. doi:10.1016/j.bcp.2010.09.012
Navas F, Perfahl S, Garino C, Salassa L, Novakova O, Navarro-Ranninger C, Bednarski PJ, Malina J, Quiroga AG (2015) Increasing DNA reactivity and in vitro antitumor activity of trans diiodido Pt(II) complexes with UVA light. J Inorg Biochem 153:211–218. doi:10.1016/j.jinorgbio.2015.07.008
Novohradsky V, Liu Z, Vojtiskova M, Sadler PJ, Brabe V, Kasparkova J (2014) Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C, N-chelating ligand. Metallomics 6:682–690. doi:10.1039/c3mt00341h
Phipps C, Lupo-Stanghellini MT, Flowers MED (2014) Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions. Bone Marrow Transplant 49:315–316. doi:10.1038/bmt.2013.159
Sahai R, Rillema DP (1986) A novel hetero-oligomer contai ning one ruthenium(II) and three platinum(II) metal centres bridged by 2,3-bis(2-pyridyl)quinoxaline. J Chem Soc, Chem Commun. doi:10.1039/C39860001133
Sawynok J (2014) Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development. Eur J Pain 18:465–481. doi:10.1002/j.1532-2149.2013.00400.x
Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265–7279
Suzuki YJ, Jain V, Park A-M, Day RM (2006) Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Rad Biol Med 40:1683–1692
Tabrizi L, Chiniforoshan H (2015) Sonochemical synthesis of Au nanowires in the III–I oxidation state bridged by 4,4′-dicyanamidobiphenyl and their application as selective CO gas sensors. Dalton Trans 44:2488. doi:10.1039/c4dt03427a
Tabrizi L, McArdle P, Erxleben A, Chiniforoshan H (2015a) Cytotoxicity and antimicrobial activity of triorganotin(IV) complexes of phenylcyanamide prepared by sonochemical synthesis. Inorg Chim Acta 438:94–104. doi:10.1016/j.ica.2015.09.011
Tabrizi L, McArdle P, Erxleben A, Chiniforoshan H (2015b) Nickel(II) and cobalt(II) complexes of lidocaine: synthesis, structure and comparative in vitro evaluations of biological perspectives. Eur J Med Chem 103:516–529. doi:10.1016/j.ejmech.2015.09.018
Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–320
Wilhelm IR, Tzabazis A, Likar R, Sittl R, Griessinger N (2010) Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. Eur J Anesthesiol 27:169–173. doi:10.1097/EJA.0b013e328330e989
Acknowledgement
We acknowledge general support from the Department of Chemistry, Isfahan University of Technology (IUT).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tabrizi, L., Chiniforoshan, H. Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives. Biometals 30, 59–70 (2017). https://doi.org/10.1007/s10534-016-9986-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-016-9986-5